Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | VERT-002 |
Synonyms | |
Therapy Description |
Limited information is currently available on VERT-002, a putative monoclonal antibody targeting MET (Nov 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
VERT-002 | VERT002|VERT 002|PFL-002|PFL002|PFL 002 | MET Antibody 31 | Limited information is currently available on VERT-002, a putative monoclonal antibody targeting MET (Nov 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06669117 | Phase Ib/II | VERT-002 | FIH Trial of VERT-002 in Patients with Locally Advanced or Metastatic Solid Tumors with MET Alterations | Recruiting | USA | 0 |